help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by TAKATA, M.
Right arrow Articles by MIYASAKA, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TAKATA, M.
Right arrow Articles by MIYASAKA, K.
Am. J. Respir. Crit. Care Med., Volume 156, Number 1, July 1997, 272-279

Intraalveolar Expression of Tumor Necrosis Factor-alpha Gene during Conventional and High-Frequency Ventilation

MASAO TAKATA, JUN ABE, HIROYUKI TANAKA, YOSHIHIRO KITANO, SHOUZABUROH DOI, TAKAO KOHSAKA, and KATSUYUKI MIYASAKA

Divisions of Pathophysiology and Immunology, National Children's Medical Research Center, Tokyo, Japan

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

The effects of conventional mechanical ventilation (CMV) and high-frequency oscillatory ventilation (HFO) on intraalveolar expression of the tumor necrosis factor-alpha (TNF-alpha ) gene were studied in surfactant-depleted rabbits. After lung lavage with saline, 13 rabbits were administered either CMV (n = 6) or HFO (n = 7) for 1 h at an FIO2 of 1.0 and a mean airway pressure of 13 cm H2O. Lung lavage was then repeated. The rabbits' RNA was extracted from the lavage cells, and mRNA for TNF-alpha was quantitated by reverse-transcription polymerase chain reaction using glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as an internal standard. At 1 h of ventilation, PaO2 was slightly lower with CMV than HFO, while lavage cell counts and cytology were similar between the two groups. The ratio of TNF-alpha mRNA to GAPDH mRNA increased with CMV (control, 0.48 ± 0.04 [SE] versus 1 h, 1.02 ± 0.14, p < 0.01) but did not change with HFO (0.55 ± 0.07 versus 0.73 ± 0.09). In a separate series of experiments, ten surfactant-depleted rabbits continued to be ventilated for 4 h either by CMV (n = 5) or HFO (n = 5). Conventional mechanical ventilation resulted in a progressive hypoxemia, decreased lung compliance, increased number of neutrophils in lung lavage fluid, and substantial morphological changes including hyaline membrane formation and neutrophil accumulation, whereas HFO was associated with minimal changes in such physiological and pathological abnormalities. These results suggest that activation of alveolar macrophages and production of proinflammatory cytokines may play a pivotal role in the early stage of ventilator-induced lung injury, and that ventilator mode (CMV or HFO) substantially modulates macrophage activation and hence the degree of lung injury.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Mechanical ventilation with intermittent positive pressure can by itself produce or worsen lung injury (1). A number of different ventilatory strategies have been developed in an attempt to reduce ventilator-induced lung injury (2). High-frequency oscillatory ventilation (HFO) is increasingly recognized as an effective alternative ventilator mode in neonatal and pediatric respiratory failure (3). Both clinical and experimental evidence suggests that HFO is associated with much less lung injury than conventional mechanical ventilation, or CMV (3, 5). However, the mechanism by which such different ventilator strategies affect progression of lung injury has not been well understood.

Various ventilator-dependent factors have been shown to be relevant in pathogenesis of ventilator-induced lung injury. These include high peak airway pressure (10), large tidal volumes (13, 14), and collapse and reopening of small airways with ventilation at low lung volumes (6, 8 15-17). A question that remains to be addressed is how such mechanical stresses and resultant insults on airway epithelium lead to diffuse lung damage, e.g., endothelial leakage, pulmonary edema, surfactant dysfunction, and hyaline membrane formation. Several studies suggest that the presence of neutrophils and their infiltration into the lung are essential in CMV-induced lung injury (6, 18). In contrast, HFO was found to be associated with less activation of neutrophils (19, 20) and less release of inflammatory chemical mediators such as platelet-activating factor (PAF) or prostaglandins (9, 21) in the lung. Thus, it seems a reasonable assumption that the inflammatory cells and mediators, which have been implicated in pathogenesis of adult respiratory distress syndrome (ARDS) (22), may also play an important role in progression of ventilator-induced lung injury. The differences in pulmonary inflammatory response may explain the marked differences in lung physiology and pathology observed between CMV and HFO (6).

The goal of the present study is to better understand the inflammatory aspects in the pathogenesis of ventilator-induced lung injury and evaluate the influence of different ventilator strategies, i.e., CMV versus HFO, on such pulmonary inflammatory response. We hypothesized that mechanical stress imposed on airway epithelium with CMV may lead to activation of alveolar macrophages, which then release proinflammatory cytokines and initiate an inflammatory cascade in the lung, including production of chemical mediators and neutrophil infiltration. On the other hand, oscillatory movement with HFO may produce less activation of alveolar macrophages, resulting in less pulmonary inflammatory response and less lung injury than CMV. With this general hypothesis, the present study investigated the role of alveolar macrophages in the early stage of ventilator-induced lung injury. Gene expression of one of the representative proinflammatory cytokines, tumor necrosis factor-alpha (TNF-alpha ), was used as an index of macrophage activation, and we compared intraalveolar TNF-alpha mRNA levels in surfactant-depleted rabbit lungs ventilated by CMV or HFO.

    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Animal Preparation

The study protocol was approved by the Institutional Animal Care and Use Committee of the National Children's Medical Research Center in Tokyo. Twenty-three male Japanese white rabbits weighing 2.39 ± 0.10 (SE) kg were premedicated with intramuscular injections of ketamine hydrochloride (10 mg/kg). A plastic catheter was inserted into an ear vein, and the animal was anesthetized by intravenous infusion of ketamine (8 mg/h) and pancuronium bromide (0.3 mg/h) in 10 ml/h of 5% dextrose in Ringer's lactate solution. A 4.0 mm ID endotracheal tube was inserted via a tracheostomy and sutured in place while the animal was manually ventilated. The animal was placed on a piston pump HFO ventilator (Humming II; Senko Medical Instruments, Tokyo, Japan) at an inspiratory oxygen fraction (FIO2) of 1.0, oscillatory frequency of 15 Hz, and mean airway pressure (MAP) of 7 cm H2O. The stroke volume of the sinusoidal oscillation was adjusted to maintain PaCO2 levels between 35 and 45 mm Hg. A fluid-filled catheter was introduced into the femoral artery for monitoring blood pressure and sampling arterial blood. Blood gas determinations were intermittently performed using a pH/blood gas analyzer (Model 178; Corning Medical, Medfield, MA). Body temperature was maintained between 37 and 39° C with a heating pad. The animals were then divided into two series of experiments.

Experimental Protocols

Series 1: Intraalveolar TNF-alpha mRNA levels with 1-hour ventilation. The purpose of this experiment was to compare the degree of activation of alveolar macrophages between CMV and HFO in the early stage of ventilator-induced lung injury. Once the 13 animals in this series were stabilized on HFO, lung lavage was performed three times with normal saline to produce surfactant depletion. This procedure in rabbits, when the animals are subsequently ventilated by CMV for several hours, produces a progressive ARDS-like lung injury characterized by diffuse microatelectasis, pulmonary edema, infiltration of neutrophils, and hyaline membrane formation (6, 18, 23). For each lavage, a 30 ml/kg aliquot of warmed saline was flushed into and out of the lung five times via tracheostomy tube and gently sucked out thereafter. Between each lavage, a sustained inflation of 30 cm H2O for 10 s was applied and MAP was raised by 2-3 cm H2O to minimize further airway collapse and progression of hypoxia. After the third lavage, the animal was restabilized on HFO with a MAP of 13 cm H2O. With several sustained inflation maneuvers, PaO2 of the animal soon returned to the prelavage level, i.e., more than 350 mm Hg. The drained lavage fluid was collected as the control lavage sample.

Each animal was then randomly assigned to receive either CMV (n = 6) or HFO (n = 7) at an FIO2 of 1.0 and MAP of 13 cm H2O for 1 h. Conventional ventilation was performed by use of the CMV mode of the Humming II ventilator. Peak inspiratory pressure and positive end-expiratory pressure (PEEP) were set at 28 and 5 cm H2O, respectively. Inspiratory time and respiratory frequency were initially set at 1.0 s and 25 breaths/min, and later adjusted to achieve normocapnia while maintaining MAP at 13 cm H2O. In the other group, HFO was performed at an oscillatory frequency of 15 Hz throughout the experiment, and normocapnia was maintained by adjusting the stroke volume. Arterial blood gases were measured every 30 min. After 1 h of mechanical ventilation, lung lavage was again performed as described above to collect the "1-hour" lavage sample.

The control and 1-hour lavage fluid samples were analyzed for cytology and mRNA quantification. The samples were centrifuged at 400 × g for 5 min at 4° C, and the cell pellets were washed twice by phosphate-buffered saline. The number of total lavage cells was counted under light microscopy, and differential cytology was performed by use of Wright-Giemsa stained preparations. The isolated cell pellets were analyzed for TNF-alpha mRNA, as described later in detail.

Series 2: Physiological changes with 4-hour ventilation.  The purpose of this experiment was to confirm whether clinically relevant physiological and pathological changes indicating lung injury would take place if the surfactant-depleted rabbits were ventilated longer either by CMV or HFO. After removal of lung surfactant by saline lavage, the 10 animals in this series were randomized to receive either CMV (n = 5) or HFO (n = 5) at an FIO2 of 1.0 and MAP of 13 cm H2O for 4 h. Exactly the same protocol as in Series 1 was used for lavage procedure and adjustment of ventilator settings. Only the duration of ventilation was different. Arterial blood gases were monitored every hour. Total respiratory system compliance (Crs) was measured before lung lavage and after 4 h of ventilation, using the passive expiratory flow-volume technique (24) with a Fleisch #0 pneumotachograph, a 3-way occlusion valve, and a personal computer-based pulmonary function testing system (Aivision Co., Tokyo, Japan), as previously described (25). After 4 h of mechanical ventilation, lung lavage was repeated and the lavage fluid samples were analyzed for cell counts and differential cytology. The animals were killed by pentobarbital overdose, their lungs were fixed by instillation of 10% buffered Formalin at a transpulmonary pressure of 15 cm H2O, and midsagittal cross sections were stained with hematoxylin and eosin for postmortem microscopic examination.

Reverse Transcription Polymerase Chain Reaction (RT-PCR)

Total RNA was extracted from the isolated lavage cell pellets of Series 1 animals by the acid guanidinium-phenol-chloroform technique, as described by Chomczynski and Sacchi (26). Two µg of total RNA was used for the synthesis of first-strand cDNA with reverse transcriptase (SuperscriptTM; Gibco BRL, Gaithersburg, MD) and random hexanucleotides (pd [N]6; Pharmacia Biotech). The reaction was terminated by heating for 10 min at 95° C before PCR.

Oligonucleotide PCR primers were synthesized on a DNA synthesizer (392 DNA/RNA synthesizer; Applied Biosystem) from the published cDNA sequences of rabbit TNF-alpha (27, 28) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (29). The sequences of these primers are shown in Table 1. We used the GAPDH gene as an internal control to standardize PCR products. The PCR reaction mixture contained one-fortieth of each cDNA sample, the upstream (5') and downstream (3') primers for TNF-alpha and GAPDH (0.3 µM of each primer), dNTP mixture (200 µM of each dNTP), and 1.25 units of Thermus aquaticus DNA polymerase (TaKaRa Biomedicals, Tokyo, Japan). Then 32P-end-labeled 5' primers (approximately 1 × 106 cpm for each primer) were added to the reaction mixture to quantify the amplified products. The amplification was performed by a thermal cycler (Perkin-Elmer Co., Norwalk, CT) for 27 cycles with denaturation at 95° C for 1 min, annealing at 60° C for 1 min, and extension at 72° C for 2 min. The PCR products were separated by electrophoresis using a 2% (wt/vol) agarose gel containing 0.5 µg/ml of ethidium bromide. Two clear bands, each corresponding to the predicted size of the amplified product for TNF-alpha mRNA (251 bp) or GAPDH mRNA (506 bp), were identified under ultraviolet transilluminator. The gels were dried, and radioactivity for each band was quantified by a radioanalytic imaging system (BAS 2000 Bio Image Analyzer; Fujix Film Co., Tokyo, Japan). The amount of TNF-alpha mRNA in each lavage sample was expressed by the radioactivity ratio of TNF-alpha mRNA to GAPDH mRNA.

                              
View this table:
[in this window]
[in a new window]
 

TABLE 1

CHARACTERISTICS OF PCR PRIMERS AND PROBES FOR SOUTHERN BLOTTING

To verify that the amplified products derived from our primer pairs were authentic, a separate set of PCR procedures was performed without radiolabeled primers. The amplified products were separated on a gel, transferred to a nylon filter membrane, and hybridized with a 32P-labeled oligonucleotide probe for either TNF-alpha or GAPDH. The sequences for these oligonucleotide probes were chosen from sequences midway between the upstream and downstream PCR primers (see Table 1). The radioactive probes hybridized only to the bands which corresponded in size to the ethidium bromide-stained gels, thereby confirming that the amplified PCR products consisted of correct TNF-alpha or GAPDH cDNA sequences.

The condition for PCR used in this study was carefully chosen to ensure that the amount of product synthesized was proportionally related to the amount of mRNA in the original preparation (30, 31). In a separate set of experiments, we analyzed the effects of PCR cycle numbers on the yield of amplified products for TNF-alpha and GAPDH under our experimental condition. At a cycle number of 27, our PCR assay was confirmed to be in the linear range during the amplification phase (Figure 1).


View larger version (13K):
[in this window]
[in a new window]
 
Figure 1.   Effects of PCR cycle numbers on the yield of amplified products for TNF-alpha and GAPDH. A set of PCR procedures with different amplification cycle numbers between 24 and 30 were carried out on the reaction mixtures containing an equal amount of a cDNA sample. The radioactivities for amplified products were counted and plotted in a logarithmic scale against the corresponding cycle number.

Data Analysis

Data are expressed as means ± SE. Changes in PaO2, Crs, total and differential cell counts, and TNF-alpha mRNA expression over the course of mechanical ventilation were evaluated by paired t tests or one-way analysis of variance (ANOVA) for repeated measures with Scheffe's tests. Differences between CMV and HFO were analyzed either by unpaired t tests or two-way ANOVA for repeated measures. An alpha error of less than 0.05 was considered significant.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Intraalveolar TNF-alpha mRNA Levels with 1-Hour Ventilation (Series 1)

Figure 2 shows changes in PaO2 values in the Series 1 experiments. With CMV, PaO2 showed a small decrease at 1 h (p < 0.05) but still remained greater than 250 mm Hg. In contrast, PaO2 did not change with HFO. Changes in cell counts and cytology in the lung lavage samples are summarized in Figure 3. The total cell counts substantially decreased in the 1-hour lavage both with CMV and HFO (p < 0.05, Figure 3A). Cells detected in the lavage fluid consisted of alveolar macrophages, neutrophils, and a few epithelial cells. In the control lavage, almost all of the recovered cells were alveolar macrophages (> 97%). In the 1-hour lavage, the recovered cells included approximately 20% neutrophils with both CMV and HFO. There was no difference in neutrophil percentage, in either the control or 1-hour lavage, between CMV and HFO (Figure 3B).


View larger version (12K):
[in this window]
[in a new window]
 
Figure 2.   Changes in PaO2 in Series 1 experiments. Values are means ± SE. dagger p < 0.05 compared with control by paired t tests. §p < 0.05 by two-way ANOVA.


View larger version (12K):
[in this window]
[in a new window]
 
Figure 3.   Changes in cell counts (A) and cytology (B) in the lavage fluid samples in Series 1 experiments. Values are means ± SE. *p < 0.01, dagger p < 0.05 compared with control by paired t tests.

Figure 4 illustrates typical PCR products obtained on gel electrophoresis by the radioanalytic imaging system. With CMV, mRNA for TNF-alpha showed a large increase in the 1-hour lavage compared with the control. In contrast, with HFO, the amount of TNF-alpha mRNA was almost similar between the control and 1-hour lavage. Changes in the relative amount of TNF-alpha message, as expressed by the mRNA ratio of TNF-alpha to GAPDH, are summarized in Figure 5. At 1 h of ventilation, TNF-alpha mRNA increased with CMV (p < 0.01) but not with HFO. The differences in changes in TNF-alpha mRNA between CMV and HFO were confirmed by a significant interaction p value (0.02) by two-way ANOVA.


View larger version (44K):
[in this window]
[in a new window]
 
Figure 4.   Typical PCR products obtained on gel electrophoresis by the radioanalytic imaging system.


View larger version (13K):
[in this window]
[in a new window]
 
Figure 5.   Changes in the relative amount of TNF-alpha gene transcripts, as expressed by the mRNA ratio of TNF-alpha to GAPDH. Values are means ± SE. *p < 0.01 compared with control by paired t tests. §p < 0.05 by two-way ANOVA.

Physiological Changes with 4-Hour Ventilation (Series 2)

Figure 6 shows changes in PaO2 values during the course of the Series 2 experiments. With CMV, PaO2 slightly decreased at 1 h and then showed a profound decrease to a level less than 100 mm Hg at 4 h (p < 0.01). In contrast, PaO2 with HFO did not show large changes and essentially remained at the prelavage level throughout the experiment. Changes in Crs and lavage cell cytology after 4-h mechanical ventilation are summarized in Figures 7 and 8. Compliance decreased with either mode of ventilation (p < 0.05), but the decrease in Crs was greater with CMV than HFO (two-way ANOVA interaction p = 0.01, Figure 7). The number of total cell counts in the 4-hour lavage were higher with CMV than HFO (p < 0.05, Figure 8A). The differential cytology demonstrated that the percentage of neutrophils was greater with CMV (95 ± 2%) than HFO (30 ± 7%) (p < 0.01, Figure 8B).


View larger version (12K):
[in this window]
[in a new window]
 
Figure 6.   Changes in PaO2 during the course of Series 2 experiments. Values are means ± SE. *p < 0.01 compared with control by one-way ANOVA for repeated measures with Scheffe's tests, Theta  p < 0.01 by two-way ANOVA.


View larger version (11K):
[in this window]
[in a new window]
 
Figure 7.   Changes in total respiratory system compliance (Crs) in Series 2 experiments. Values are means ± SE. *p < 0.01, dagger p < 0.05 compared with control by paired t tests. §p < 0.05 by two-way ANOVA.


View larger version (10K):
[in this window]
[in a new window]
 
Figure 8.   The total cell counts (A) and cytology (B) in the 4-hour lavage fluid samples in Series 2 experiments. Values are means ± SE. Theta p < 0.01, §p < 0.05; significantly different by unpaired t tests.

Figure 9 shows typical pathological findings obtained with 4 h of CMV or HFO. Extensive hyaline membrane formation and neutrophil accumulation in the terminal airways and alveoli were observed with CMV (Figure 9A). In contrast, the lungs ventilated with HFO showed much less hyaline membrane formation and neutrophil infiltration than CMV, and most of the alveoli were still well expanded with little evidence of degradation of normal lung architecture (Figure 9B).


View larger version (148K):
[in this window]
[in a new window]
 


View larger version (126K):
[in this window]
[in a new window]
 
Figure 9.   Typical pathological findings obtained with 4 h of CMV (A) and HFO (B) in Series 2 experiments.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

In surfactant-depleted rabbits, we found that CMV for only 1 h produced large increases in TNF-alpha mRNA in the intraalveolar cells, presumably the alveolar macrophages, while HFO of the same duration produced minimal increases in TNF-alpha gene transcripts. With 4 h of mechanical ventilation, rabbits undergoing CMV developed substantial physiological and pathological changes indicating lung injury, whereas those on HFO did not. These findings suggest that activation of alveolar macrophages and production of proinflammatory cytokines such as TNF-alpha may play a pivotal role in the early stage of CMV-induced lung injury, and that HFO may produce less activation of alveolar macrophages, thereby leading to less lung injury than CMV.

In the present study we used saline-lavaged ventilated rabbits, because that is an established, extensively investigated model of ventilator-induced lung injury. A number of investigators have used this model to evaluate the effects of different ventilator strategies on lung injury, particularly the effects of HFO as compared with CMV (6, 8, 18, 23). Physiological and pathological profiles of the progressive ARDS-like lung injury in these rabbits have been well characterized and found experimentally reproducible. The Series 2 experiments showed that CMV of 4 h in these rabbits produced a progressive hypoxemia, decreased lung compliance, increased number of neutrophils in the lung lavage fluid, and substantial morphological changes in the lungs, including hyaline membrane formation and neutrophil accumulation. In contrast, HFO of 4 h was associated with minimal changes in lung physiology and pathology. These findings, essentially consistent with the previous studies in the literature, demonstrated that with the experimental protocol employed in the present study, the different ventilator strategies (CMV versus HFO) actually produce clinically significant differences in the degree of lung injury in these rabbits.

With only 1 h of mechanical ventilation in the Series 1 experiments, however, there were virtually no large differences in blood gas or lung lavage cytology between CMV and HFO. The PaO2 at 1 h was slightly lower with CMV, but the animal was still well oxygenated. The cell counts decreased at 1 h with both CMV and HFO, presumably because the control lavage removed most of the alveolar macrophages, and a 1 h period was not long enough to recruit cells from the blood. The neutrophil percentage in the 1-hour lavage increased but remained relatively small (about 20%) in both groups, without any difference between CMV and HFO. Thus, after 1 h of mechanical ventilation, the pathological process of ventilator- induced lung injury in these rabbits had not been apparent or fully initiated with either CMV or HFO.

Despite the lack of significant abnormalities in the physiological parameters, the RT-PCR technique demonstrated a clear difference in the amount of TNF-alpha mRNA in the lavage cells between CMV and HFO at 1 h. This implies that the activation of intraalveolar cells occurs very shortly after the initiation of CMV, before any physiological signs of lung injury become apparent. Moreover, HFO substantially attenuated the degree of the cell activation and cytokine mRNA expression. Although the levels of rabbit TNF-alpha protein were not directly measured in this study, the enhanced TNF-alpha gene expression at the transcriptional level would soon lead to actual production of TNF-alpha protein with CMV. The increased TNF-alpha protein should then initiate inflammatory cascade in the lung, resulting in production of lipid mediators such as PAF or prostaglandins and neutrophil infiltration and activation in the alveolar space, as observed in the prior studies by ourselves (19, 21) and others (6, 20). Once all of the above inflammatory processes are fully activated in the lung, significant physiological and pathological abnormalities would take place, as in the Series 2 animals with CMV. Our findings thus provide a molecular basis for how different ventilator patterns influence the initial pulmonary inflammatory response in the early stage of ventilator-induced lung injury. The degree of activation of intraalveolar cells and cytokine gene expression may later lead to the marked differences in the degree of lung injury between CMV and HFO.

We performed the RT-PCR analysis for TNF-alpha on the total cell component of each lavage sample, without separating the macrophages from neutrophils. This was because the rabbit alveolar macrophages stimulated by ventilation had diverse and nonhomogeneous specific gravities such that ordinary Ficoll-Hypaque centrifuge methods failed to reliably separate them from the neutrophils. In addition, we did not wish to purify the macrophages by use of any adherence techniques, which may result in inadvertent induction of cytokine mRNA expression. We were therefore unable to draw a definite conclusion regarding the cell source for the increased TNF-alpha gene transcripts. However, there is ample evidence in the literature that the predominant sources of TNF-alpha in the lung are the alveolar macrophages (32). Xing and colleagues found in rat lungs that the neutrophils can produce TNF-alpha protein in response to lipopolysaccharide stimulation, but the alveolar macrophages serve as the predominant source for TNF-alpha in the early stage of lung inflammation (33). Moreover, we found in two of the CMV-treated rabbits that almost all of the cells (> 95%) recovered in the 1-hour lavage were the macrophages, yet TNF-alpha mRNA substantially increased similarly to the other CMV-treated animals. Thus, it seems reasonable to speculate that the major source of the increased TNF-alpha message in this study were the alveolar macrophages, not neutrophils.

Among the numerous cytokines and chemical mediators produced by alveolar macrophages, we focused on TNF-alpha and used its gene transcripts as an index of macrophage activation. Our main goal was to quantitatively evaluate the level of macrophage activation in the early stage of ventilator-induced lung injury. The relative impact of TNF-alpha as compared with those of other proinflammatory mediators in pathogenesis of lung injury was not directly tested and hence remains to be further investigated. However, TNF-alpha has been shown to be a principal mediator in the early phase of various inflammatory processes, with substantial effects and stimulations on other inflammatory cells and mediators (32). Tumor necrosis factor-alpha is now recognized as the key proinflammatory cytokine to initiate and amplify the process of multiorgan failure during sepsis, and it has also been implicated in progression of ARDS (22, 32, 34). Taken together, these findings make it likely that TNF-alpha may also play an important role in the initial stage of ventilator-induced lung injury. The similar TNF-alpha -triggered inflammatory cascade, as observed in sepsis/ARDS syndrome, may explain a large part of the progression of lung injury with CMV, though the first triggering signal is not chemical (lipopolysaccharide) but mechanical insult (stress on airway epithelium).

Since the advent of mechanical ventilation, clinicians and scientists have realized that intermittent positive-pressure ventilation per se exacerbates lung injury. Experimental studies have clarified the relative importance of various ventilator-dependent factors in the progression of lung injury (1). High peak inspiratory pressures (10) or large tidal volumes (13, 14) are generally accepted as the key factors, imposing overdistending stresses on airway epithelium and producing epithelial and endothelial damages. Recent studies further demonstrated that moderate levels of PEEP may actually protect the lung from ventilator-induced damage (13, 16, 17), consistent with the notion made by Robertson that intermittent collapse and reopening of small airways or alveolar ducts and the resultant high shear stresses on airway epithelium are responsible for CMV-induced lung injury (15). Bryan and Froese utilized this concept to explain why HFO with appropriate volume-recruitment protocols does not produce epithelial damage (6, 8). Based on these findings the currently accepted strategies for preventing lung injury focus mainly on optimization of such mechanical factors, i.e. maintaining the lowest possible inspiratory pressures or tidal volumes while volume-recruiting the lung with active application of PEEP (1, 2) or using newly developed, less invasive modes of ventilation such as HFO in pediatrics (3).

The results of this study, together with the previous reports clarifying the role of neutrophils (6, 18) and chemical mediators (9, 21), suggest that the inflammatory events are also involved from the very early stage of ventilator-induced lung injury. Both the mechanical and inflammatory processes appear to be essential for progression of diffuse lung damage during mechanical ventilation. Therefore, in addition to the use of less invasive ventilator strategies such as HFO, pharmacological or immunological modulation of the inflammatory cells and mediators may provide a useful way to attenuate ventilator-induced lung injury in neonatal and adult respiratory distress syndrome.

    Footnotes

Correspondence and requests for reprints should be addressed to Masao Takata, M.D., Ph.D., Pathophysiology Research, National Children's Medical Research Center, 3-35-31 Taishido, Seyagaya, Tokyo 154, Japan.

(Received in original form July 18, 1996 and in revised form February 10, 1997).

Acknowledgments: The authors thank Doctors Y. Imai, T. Kawano, and K. D. Bloch for critical reviews of this work.

Supported by Grant H8-PK8-02, Ministry of Health and Welfare, Japan.

    References
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1. Parker, J. C., L. A. Hernandez, and K. Peevy. 1993. Mechanisms of ventilator-induced lung injury. Crit. Care Med 21: 131-143 [Medline].

2. Marini, J. J. 1993. Mechanical ventilation and newer ventilatory techniques. In R. C. Bone, D. R. Dantzker, R. B. George, R. A. Matthay, and H. Y. Reynolds, editors. Pulmonary and Critical Care Medicine, Vol. 3, Part R, Chapter 5. Mosby-Year Book, Inc., St. Louis. 1-26.

3. Clark, R. H., D. R. Gerstmann, D. J. Null, and R. A. deLemos. 1992. Prospective randomized comparison of high-frequency oscillatory and conventional ventilation in respiratory distress syndrome. Pediatrics 89: 5-12 [Abstract/Free Full Text].

4. Ogawa, Y., K. Miyasaka, T. Kawano, S. Imura, K. Inukai, K. Okuyama, K. Oguchi, H. Togari, H. Nishida, and J. Mishina. 1993. A multicenter randomized trial of high frequency oscillatory ventilation as compared with conventional mechanical ventilation in preterm infants with respiratory failure. Early Hum. Dev 32: 1-10 [Medline].

5. Arnold, J. H., J. H. Hanson, F. L. Toro, J. Gutierrez, R. J. Berens, and D. L. Anglin. 1994. Prospective, randomized comparison of high-frequency oscillatory ventilation and conventional mechanical ventilation in pediatric respiratory failure. Crit. Care Med 22: 1530-1539 [Medline].

6. Hamilton, P. P., A. Onayemi, J. A. Smyth, J. E. Gillan, E. Cutz, A. B. Froese, and A. C. Bryan. 1983. Comparison of conventional and high-frequency ventilation: oxygenation and lung pathology. J. Appl. Physiol 55: 131-138 [Free Full Text].

7. Delemos, R. A., J. J. Coalson, D. R. Gerstmann, D. J. Null, N. B. Ackerman, M. B. Escobedo, J. L. Robotham, and T. J. Kuehl. 1987. Ventilatory management of infant baboons with hyaline membrane disease: the use of high frequency ventilation. Pediatr. Res 21: 594-602 [Medline].

8. McCulloch, P. R., P. G. Forkert, and A. B. Froese. 1988. Lung volume maintenance prevents lung injury during high frequency oscillatory ventilation in surfactant-deficient rabbits. Am. Rev. Respir. Dis 137: 1185-1192 [Medline].

9. Meredith, K. S., R. A. deLemos, J. J. Coalson, R. J. King, D. R. Gerstmann, R. Kumar, T. J. Kuehl, D. C. Winter, A. Taylor, R. H. Clark, and D. M. J. Null. 1989. Role of lung injury in the pathogenesis of hyaline membrane disease in premature baboons. J. Appl. Physiol 66: 2150-2158 [Abstract/Free Full Text].

10. Egan, E. A., R. M. Nelson, and R. E. Olver. 1976. Lung inflation and alveolar permeability to non-electrolytes in the adult sheep in vivo. J. Physiol. (Lond.) 260: 409-424 [Abstract/Free Full Text].

11. Parker, J. C., M. I. Townsley, B. Rippe, A. E. Taylor, and J. Thigpen. 1984. Increased microvascular permeability in dog lungs due to high peak airway pressures. J. Appl. Physiol 57: 1809-1816 [Abstract/Free Full Text].

12. Dreyfuss, D., G. Basset, P. Soler, and G. Saumon. 1985. Intermittent positive-pressure hyperventilation with high inflation pressures produces pulmonary microvascular injury in rats. Am. Rev. Respir. Dis. 132: 880-884 [Medline].

13. Dreyfuss, D., P. Soler, G. Basset, and G. Saumon. 1988. High inflation pressure pulmonary edema: respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am. Rev. Respir. Dis. 137: 1159-1164 [Medline].

14. Hernandez, L. A., K. J. Peevy, A. A. Moise, and J. C. Parker. 1989. Chest wall restriction limits high airway pressure-induced lung injury in young rabbits. J. Appl. Physiol. 66: 2364-2368 [Abstract/Free Full Text].

15. Robertson, B.. 1976. Current and counter-current theories on lung surfactant. Scand. J. Respir. Dis 57: 199-207 [Medline].

16. Sandhar, B. K., D. J. Niblett, E. P. Argiras, M. S. Dunnill, and M. K. Sykes. 1988. Effects of positive end-expiratory pressure on hyaline membrane formation in a rabbit model of the neonatal respiratory distress syndrome. Intensive Care Med 14: 538-546 [Medline].

17. Muscedere, J. G., J. B. Mullen, K. Gan, and A. S. Slutsky. 1994. Tidal ventilation at low airway pressures can augment lung injury. Am. J. Respir. Crit. Care Med. 149: 1327-1334 [Abstract].

18. Kawano, T., S. Mori, M. Cybulsky, R. Burger, A. Ballin, E. Cutz, and A. C. Bryan. 1987. Effect of granulocyte depletion in a ventilated surfactant-depleted lung. J. Appl. Physiol 62: 27-33 [Abstract/Free Full Text].

19. Matsuoka, T., T. Kawano, and K. Miyasaka. 1994. Role of high-frequency ventilation in surfactant-depleted lung injury as measured by granulocytes. J. Appl. Physiol 76: 539-544 [Abstract/Free Full Text].

20. Sugiura, M., P. R. McCulloch, S. Wren, R. H. Dawson, and A. B. Froese. 1994. Ventilator pattern influences neutrophil influx and activation in atelectasis-prone rabbit lung. J. Appl. Physiol 77: 1355-1365 [Abstract/Free Full Text].

21. Imai, Y., T. Kawano, K. Miyasaka, M. Takata, T. Imai, and K. Okuyama. 1994. Inflammatory chemical mediators during conventional and high frequency oscillatory ventilation. Am. J. Respir. Crit. Care Med 150: 1550-1554 [Abstract].

22. Bone, R. C. 1993. The acute respiratory distress syndrome (ARDS). In R. C. Bone, D. R. Dantzker, R. B. George, R. A. Matthay, and H. Y. Reynolds, editors. Pulmonary and Critical Care Medicine. Vol. 3, Part R, Chapter 3. Mosby-Year Book, Inc., St. Louis. 1-9.

23. Lachmann, B., B. Robertson, and J. Vogel. 1980. In vivo lung lavage as an experimental model of the respiratory distress syndrome. Acta Anaesthesiol. Scand 24: 231-236 [Medline].

24. LeSouef, P. N., S. J. England, and A. C. Bryan. 1984. Passive respiratory mechanics in newborns and children. Am. Rev. Respir. Dis 129: 552-556 [Medline].

25. Hu, H., M. Takata, I. Kusakawa, M. Fujita, and K. Miyasaka. 1995. Intratracheal administration of phosphodiesterase III inhibitor attenuates bronchoconstriction in cats: a preliminary report. Pediatr. Pulmonol 19: 360-364 [Medline].

26. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem 162: 156-159 [Medline].

27. Ito, H., S. Yamamoto, S. Kuroda, H. Sakamoto, J. Kajihara, T. Kiyota, H. Hayashi, M. Kato, and M. Seko. 1986. Molecular cloning and expression in Escherichia coli of the cDNA coding for rabbit tumor necrosis factor. DNA 5: 149-156 [Medline].

28. Ito, H., T. Shirai, S. Yamamoto, M. Akira, S. Kawahara, C. W. Todd, and R. B. Wallace. 1986. Molecular cloning of the gene encoding rabbit tumor necrosis factor. DNA 5: 157-165 [Medline].

29. Applequist, S. E., U. Keyna, M. R. Calvin, G. B. Beck-Engeser, C. Raman, and H. M. Jack. 1995. Sequence of the rabbit glyceraldehyde-3-phosphate dehydrogenase-encoding cDNA. Gene 163: 325-326 [Medline].

30. Abe, J., J. Forrester, T. Nakahara, J. A. Lafferty, B. L. Kotzin, and D. Y. Leung. 1991. Selective stimulation of human T cells with streptococcal erythrogenic toxins A and B.  J. Immunol 146: 3747-3750 [Abstract].

31. Choi, Y. W., B. Kotzin, L. Herron, J. Callahan, P. Marrack, and J. Kappler. 1989. Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc. Natl. Acad. Sci. U.S.A. 86: 8941-8945 [Abstract/Free Full Text].

32. Ulich, T. R. 1993. TNF. In J. Kelley, editor. Cytokines of the Lung. Marcel Dekker, New York. 307-332.

33. Xing, Z., H. Kirpalani, D. Torry, M. Jordana, and J. Gauldie. 1993. Polymorphonuclear leukocytes as a significant source of tumor necrosis factor-alpha in endotoxin-challenged lung tissue. Am. J. Pathol 143: 1009-1015 [Abstract].

34. Tracey, K. J., S. F. Lowry, and A. Cerami. 1988. Cachetin/TNF-alpha in septic shock and septic adult respiratory distress syndrome. Am. Rev. Respir. Dis 138: 1377-1379 [Medline].

35. Hyers, T. M., S. M. Tricomi, P. A. Dettenmeier, and A. A. Fowler. 1991. Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am. Rev. Respir. Dis 144: 268-271 [Medline].

36. Suter, P. M., S. Suter, E. Girardin, L. P. Roux, G. E. Grau, and J. M. Dayer. 1992. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am. Rev. Respir. Dis. 145: 1016-1022 [Medline].

37. Tran Van Nhieu, J., B. Misset, F. Lebargy, J. Carlet, and J. F. Bernaudin. 1993. Expression of tumor necrosis factor-alpha gene in alveolar macrophages from patients with the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 147: 1585-1589 [Medline].





This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
M. R. Wilson, K. P. O'Dea, D. Zhang, A. D. Shearman, N. van Rooijen, and M. Takata
Role of Lung-marginated Monocytes in an In Vivo Mouse Model of Ventilator-induced Lung Injury
Am. J. Respir. Crit. Care Med., May 15, 2009; 179(10): 914 - 922.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. A. Nonas, L. M. Vinasco, S. F. Ma, J. R. Jacobson, A. A. Desai, S. M. Dudek, C. Flores, P. M. Hassoun, L. Sam, S. Q. Ye, et al.
Use of consomic rats for genomic insights into ventilator-associated lung injury
Am J Physiol Lung Cell Mol Physiol, August 1, 2007; 293(2): L292 - L302.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. R. Wilson, M. E. Goddard, K. P. O'Dea, S. Choudhury, and M. Takata
Differential roles of p55 and p75 tumor necrosis factor receptors on stretch-induced pulmonary edema in mice
Am J Physiol Lung Cell Mol Physiol, July 1, 2007; 293(1): L60 - L68.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
P. Truffert, J. Paris-Llado, B. Escande, J.-F. Magny, G. Cambonie, E. Saliba, G. Thiriez, V. Zupan-Simunek, T. Blanc, J.-C. Roze, et al.
Neuromotor Outcome at 2 Years of Very Preterm Infants Who Were Treated With High-Frequency Oscillatory Ventilation or Conventional Ventilation for Neonatal Respiratory Distress Syndrome
Pediatrics, April 1, 2007; 119(4): e860 - e865.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. A. Frank, P. E. Parsons, and M. A. Matthay
Pathogenetic Significance of Biological Markers of Ventilator-Associated Lung Injury in Experimental and Clinical Studies
Chest, December 1, 2006; 130(6): 1906 - 1914.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. H. Kim, M. H. Suk, D. W. Yoon, S. H. Lee, G. Y. Hur, K. H. Jung, H. C. Jeong, S. Y. Lee, S. Y. Lee, I. B. Suh, et al.
Inhibition of matrix metalloproteinase-9 prevents neutrophilic inflammation in ventilator-induced lung injury
Am J Physiol Lung Cell Mol Physiol, October 1, 2006; 291(4): L580 - L587.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
N. G. Hall, Y. Liu, J. M. Hickman-Davis, G. C. Davis, C. Myles, E. J. Andrews, S. Matalon, and J. D. Lang Jr.
Bactericidal Function of Alveolar Macrophages in Mechanically Ventilated Rabbits
Am. J. Respir. Cell Mol. Biol., June 1, 2006; 34(6): 719 - 726.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. Miyao, Y. Suzuki, K. Takeshita, H. Kudo, M. Ishii, R. Hiraoka, K. Nishio, T. Tamatani, S. Sakamoto, M. Suematsu, et al.
Various adhesion molecules impair microvascular leukocyte kinetics in ventilator-induced lung injury
Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1059 - L1068.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Tsuchida, D. Engelberts, M. Roth, C. McKerlie, M. Post, and B. P. Kavanagh
Continuous positive airway pressure causes lung injury in a model of sepsis
Am J Physiol Lung Cell Mol Physiol, October 1, 2005; 289(4): L554 - L564.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
L. N. Tremblay and A. S. Slutsky
Pathogenesis of ventilator-induced lung injury: trials and tribulations
Am J Physiol Lung Cell Mol Physiol, April 1, 2005; 288(4): L596 - L598.
[Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. R. Wilson, S. Choudhury, and M. Takata
Pulmonary inflammation induced by high-stretch ventilation is mediated by tumor necrosis factor signaling in mice
Am J Physiol Lung Cell Mol Physiol, April 1, 2005; 288(4): L599 - L607.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
L. L. Farias, D. S. Faffe, D. G. Xisto, M. C. E. Santana, R. Lassance, L. F. M. Prota, M. B. Amato, M. M. Morales, W. A. Zin, and P. R. M. Rocco
Positive end-expiratory pressure prevents lung mechanical stress caused by recruitment/derecruitment
J Appl Physiol, January 1, 2005; 98(1): 53 - 61.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Choudhury, M. R. Wilson, M. E. Goddard, K. P. O'Dea, and M. Takata
Mechanisms of early pulmonary neutrophil sequestration in ventilator-induced lung injury in mice
Am J Physiol Lung Cell Mol Physiol, November 1, 2004; 287(5): L902 - L910.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
H. Wrigge, U. Uhlig, J. Zinserling, E. Behrends-Callsen, G. Ottersbach, M. Fischer, S. Uhlig, and C. Putensen
The Effects of Different Ventilatory Settings on Pulmonary and Systemic Inflammatory Responses During Major Surgery
Anesth. Analg., March 1, 2004; 98(3): 775 - 781.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
U. Uhlig, H. Fehrenbach, R. A. Lachmann, T. Goldmann, B. Lachmann, E. Vollmer, and S. Uhlig
Phosphoinositide 3-OH Kinase Inhibition Prevents Ventilation-induced Lung Cell Activation
Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 201 - 208.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. M. Steinberg, H. J. Schiller, J. M. Halter, L. A. Gatto, H.-M. Lee, L. A. Pavone, and G. F. Nieman
Alveolar Instability Causes Early Ventilator-induced Lung Injury Independent of Neutrophils
Am. J. Respir. Crit. Care Med., January 1, 2004; 169(1): 57 - 63.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. G. Laffey, R. P. Jankov, D. Engelberts, A. K. Tanswell, M. Post, T. Lindsay, J. B. Mullen, A. Romaschin, D. Stephens, C. McKerlie, et al.
Effects of Therapeutic Hypercapnia on Mesenteric Ischemia-Reperfusion Injury
Am. J. Respir. Crit. Care Med., December 1, 2003; 168(11): 1383 - 1390.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. R. Wilson, S. Choudhury, M. E. Goddard, K. P. O'Dea, A. G. Nicholson, and M. Takata
High tidal volume upregulates intrapulmonary cytokines in an in vivo mouse model of ventilator-induced lung injury
J Appl Physiol, October 1, 2003; 95(4): 1385 - 1393.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
S. Fernandez-Serrano, J. Dorca, M. Coromines, J. Carratala, F. Gudiol, and F. Manresa
Molecular Inflammatory Responses Measured in Blood of Patients with Severe Community-Acquired Pneumonia
Clin. Vaccine Immunol., September 1, 2003; 10(5): 813 - 820.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J-D. Ricard, D. Dreyfuss, and G. Saumon
Ventilator-induced lung injury
Eur. Respir. J., August 1, 2003; 22(42_suppl): 2s - 9s.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. Dreyfuss, J.-D. Ricard, and G. Saumon
On the Physiologic and Clinical Relevance of Lung-borne Cytokines during Ventilator-induced Lung Injury
Am. J. Respir. Crit. Care Med., June 1, 2003; 167(11): 1467 - 1471.
[Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. M. Waters, P. H. S. Sporn, M. Liu, and J. J. Fredberg
Cellular biomechanics in the lung
Am J Physiol Lung Cell Mol Physiol, September 1, 2002; 283(3): L503 - L509.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. E. Sinclair, D. A. Kregenow, W. J. E. Lamm, I. R. Starr, E. Y. Chi, and M. P. Hlastala
Hypercapnic Acidosis Is Protective in an In Vivo Model of Ventilator-induced Lung Injury
Am. J. Respir. Crit. Care Med., August 1, 2002; 166(3): 403 - 408.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Tasiemski, H. Hammad, F. Vandenbulcke, C. Breton, T. J. Bilfinger, J. Pestel, and M. Salzet
Presence of chromogranin-derived antimicrobial peptides in plasma during coronary artery bypass surgery and evidence of an immune origin of these peptides
Blood, June 28, 2002; 100(2): 553 - 559.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
Y. Imai, S. Nakagawa, Y. Ito, T. Kawano, A. S. Slutsky, and K. Miyasaka
Comparison of lung protection strategies using conventional and high-frequency oscillatory ventilation
J Appl Physiol, October 1, 2001; 91(4): 1836 - 1844.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
J.-D. Ricard and D. Dreyfuss
Cytokines During Ventilator-Induced Lung Injury: A Word of Caution
Anesth. Analg., August 1, 2001; 93(2): 251 - 252.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J.-D. RICARD, D. DREYFUSS, and G. SAUMON
Production of Inflammatory Cytokines in Ventilator-Induced Lung Injury: A Reappraisal
Am. J. Respir. Crit. Care Med., April 1, 2001; 163(5): 1176 - 1180.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
H.-D. HELD, S. BOETTCHER, L. HAMANN, and S. UHLIG
Ventilation-Induced Chemokine and Cytokine Release Is Associated with Activation of Nuclear Factor-{kappa}B and Is Blocked by Steroids
Am. J. Respir. Crit. Care Med., March 1, 2001; 163(3): 711 - 716.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
H. Imanaka, M. Shimaoka, N. Matsuura, M. Nishimura, N. Ohta, and H. Kiyono
Ventilator-Induced Lung Injury Is Associated with Neutrophil Infiltration, Macrophage Activation, and TGF-{beta}1 mRNA Upregulation in Rat Lungs
Anesth. Analg., February 1, 2001; 92(2): 428 - 436.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
G. Moriette, J. Paris-Llado, H. Walti, B. Escande, J.-F. Magny, G. Cambonie, G. Thiriez, S. Cantagrel, T. Lacaze-Masmonteil, L. Storme, et al.
Prospective Randomized Multicenter Comparison of High-Frequency Oscillatory Ventilation and Conventional Ventilation in Preterm Infants of Less Than 30 Weeks With Respiratory Distress Syndrome
Pediatrics, February 1, 2001; 107(2): 363 - 372.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. G. LAFFEY, M. TANAKA, D. ENGELBERTS, X. LUO, S. YUAN, A. KEITH TANSWELL, M. POST, T. LINDSAY, and B. P. KAVANAGH
Therapeutic Hypercapnia Reduces Pulmonary and Systemic Injury following In Vivo Lung Reperfusion
Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2287 - 2294.
[Abstract] [Full Text]


Home page
PediatricsHome page
D. W. Thibeault, S. M. Mabry, I. I. Ekekezie, and W. E. Truog
Lung Elastic Tissue Maturation and Perturbations During the Evolution of Chronic Lung Disease
Pediatrics, December 1, 2000; 106(6): 1452 - 1459.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
B. A. YODER, T. SILER-KHODR, V. T. WINTER, and J. J. COALSON
High-frequency Oscillatory Ventilation . Effects on Lung Function, Mechanics, and Airway Cytokines in the Immature Baboon Model for Neonatal Chronic Lung Disease
Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1867 - 1876.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. Mourgeon, N. Isowa, S. Keshavjee, X. Zhang, A. S. Slutsky, and M. Liu
Mechanical stretch stimulates macrophage inflammatory protein-2 secretion from fetal rat lung cells
Am J Physiol Lung Cell Mol Physiol, October 1, 2000; 279(4): L699 - L706.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. A. Krishnan and R. G. Brower
High-Frequency Ventilation for Acute Lung Injury and ARDS
Chest, September 1, 2000; 118(3): 795 - 807.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. DURAND, M. BACHELET, F. BRUNET, M. J. RICHARD, J.-F. DHAINAUT, J. DALL'AVA, and B. S. POLLA
Inducibility of the 70 kD Heat Shock Protein in Peripheral Blood Monocytes Is Decreased in Human Acute Respiratory Distress Syndrome and Recovers Over Time
Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 286 - 292.
[Abstract] [Full Text]


Home page
Anesth. Analg.Home page
N. Kotani, H. Hashimoto, D. I. Sessler, T. Yasuda, T. Ebina, M. Muraoka, and A. Matsuki
Expression of Genes for Proinflammatory Cytokines in Alveolar Macrophages During Propofol and Isoflurane Anesthesia
Anesth. Analg., November 1, 1999; 89(5): 1250 - 1250.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
Y. Imai, T. Kawano, S. Iwamoto, S. Nakagawa, M. Takata, and K. Miyasaka
Intratracheal anti-tumor necrosis factor-alpha antibody attenuates ventilator-induced lung injury in rabbits
J Appl Physiol, August 1, 1999; 87(2): 510 - 515.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. CHIUMELLO, G. PRISTINE, and A. S. SLUTSKY
Mechanical Ventilation Affects Local and Systemic Cytokines in an Animal Model of Acute Respiratory Distress Syndrome
Am. J. Respir. Crit. Care Med., July 1, 1999; 160(1): 109 - 116.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. Pugin, I. Dunn, P. Jolliet, D. Tassaux, J.-L. Magnenat, L. P. Nicod, and J.-C. Chevrolet
Activation of human macrophages by mechanical ventilation in vitro
Am J Physiol Lung Cell Mol Physiol, December 1, 1998; 275(6): L1040 - L1050.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. S. SLUTSKY and L. N. TREMBLAY
Multiple System Organ Failure . Is Mechanical Ventilation a Contributing Factor?
Am. J. Respir. Crit. Care Med., June 1, 1998; 157(6): 1721 - 1725.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. DREYFUSS and G. SAUMON
Ventilator-induced Lung Injury . Lessons from Experimental Studies
Am. J. Respir. Crit. Care Med., January 1, 1997; 157(1): 294 - 323.
[Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by TAKATA, M.
Right arrow Articles by MIYASAKA, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TAKATA, M.
Right arrow Articles by MIYASAKA, K.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1997 American Thoracic Society